US Patent Issued to NOVMETAPHARMA, SEOUL NATIONAL UNIVERSITY HOSPITAL, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on Feb. 24 for "Use of cyclo(His-Pro) (CHP) for preventing, alleviating or treating peritoneal fibrosis" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,396, issued on Feb. 24, was assigned to NOVMETAPHARMA Co. LTD. (Seoul, South Korea), SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea) and SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Use of cyclo(His-Pro) (CHP) for preventing, alleviating or treating peritoneal fibrosis" was invented by Hoe Yune Jung (Pohang-si, South Korea), Do Hyun Lee (Pohang-si, South Korea), Heon Jong Lee (Incheon, South Korea), Yon Su Kim (Seoul, South Korea) and Seung Hee Yang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A cyclo(His-Pro)(CHP) is useful for preventing, alleviating or treating peritoneal fibrosis. A pharmaceutica...